In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs

In vitro microbiological characterization of a novel azalide, two triamilides and an azalide ketal against bovine and porcine respiratory pathogens.

Several novel 15-membered-ring macrolide agents (azalide 1, triamilides 2 and 3, and the azalide 3,6-ketal 4) were identified as potential antibacterial agents against Mannheimia (formerly named as Pasteurella) haemolytica, Pasteurella multocida, Haemophilus somnus and Actinobacillus pleuropneumoniae, important etiological agents of bovine and porcine respiratory disease. Compound 3 is the majo...

Isolation and typing of Pasteurella multocida poultry isolates from Iran

Isolation typing of Pasteurella multocida poultry isolates from IRAN

Pharmacokinetic / Pharmacodynamic Relationships of a Combination of Amoxicillin and Clavulanic Acid against Streptococcus Suis, Pasteurella Multocida and Actinobacillus Pleuropneumoniae

Conclusions: From these results, the combination of AMX+CA should have an excellent therapeutic effect against Ss and Pm and up to the MIC 50 of App (81% of the isolates) as T >MIC of 40% is considered the required minimum effective level (3). This was confirmed in the artificial challenge study using an App isolate with an MIC of 0.25μg/ml (4). AMX is very rapidly absorbed and excreted (5) whe...

Evaluation of the RapID NH system for identification of Haemophilus somnus, Pasteurella multocida, Pasteurella haemolytica, and Actinobacillus pleuropneumoniae isolated from cattle and pigs with respiratory disease.

Haemophilus somnus, Pasteurella haemolytica, Pasteurella multocida, and Actinobacillus pleuropneumoniae from cattle and pigs with respiratory disease were used to evaluate the RapID NH system (Innovative Diagnostics, Atlanta, Ga.). Minor modifications of the RapID NH system to include animal source and growth requirements would permit the identification of all isolates tested.